����Vlog

Biography

Kathryn V. Blake, PharmD, is the Director of the �þþþþþþþ�Ʒ Center for Pharmacogenomics and Translational Research, and a principal research scientist for �þþþþþþþ�Ʒ Children's Health. She is Professor of Pharmacy, Mayo Clinic College of Medicine and Science. She received her B.S. in Zoology from the University of North Carolina and her Doctor of Pharmacy degree from the University of Florida. She completed a residency and fellowship in pulmonary pharmacotherapy at the University of Florida. She is board certified in Pharmacotherapy and is a fellow of the American College of Clinical Pharmacy. Her research interests are in pediatric asthma, devices use in clinical trials, and pharmacogenomics. She has been a PI since 1999 for the American Lung Association Airways Clinical Research Centers network, the NIH funded AsthmaNet from 2015 to 2017, and the IGNITE (Implementing Genomics in Practice) network since 2015. She is the Director for the American Lung Association Biorepository housed at the �þþþþþþþ�Ʒ Delaware facility. This biorepository will house nearly 500,000 specimens collected by the NIH funded Lung Health Cohort Study conducted by the American Lung Association Airways Clinical Research Centers network. She has been a PI or co-I on over 100 clinical trials. Dr. Blake has received funding from NIH for a K23 award in asthma pharmacogenomics and two R01 for studies of asthma adherence and streamlining pediatric clinical trials. She is PI of the NIH funded MATCH trial that was conducted and recently completed by the ALA-ACRC network. She also received funding from ALA to evaluate a digital diary completed by parents to track respiratory tract infections in young children. She currently directs the Pharmacogenomics Clinical Service Program at �þþþþþþþ�Ʒ Children's Health, serving four institutions across Delaware and Florida. Dr. Blake has held numerous national leadership and advisory roles. From 2018 to 2020, she served on the National Heart, Lung, and Blood Institute's Working Group—a Federal Advisory Committee—tasked with updating the EPR-3 Guidelines for the Diagnosis and Management of Asthma. She chaired the American Society of Health-System Pharmacists (ASHP) Research Advisory Council from 2021 to 2023 and has served on the FDA's Pulmonary and Allergy Drugs Advisory Committee. She is currently an NIH-appointed member of the Interdisciplinary Clinical Care in Specialty Care Settings Study Section of the NIH Center for Scientific Review. Additionally, she serves as Vice Chair of the American Lung Association's Scientific Advisory Committee and Chair of �þþþþþþþ�Ʒ Institutional Review Board 2. Dr. Blake has authored over 150 publications in pediatric asthma and pharmacogenomics, along with 12 book chapters focused on asthma.